Abigail Altabef

4.1k total citations · 1 hit paper
6 papers, 558 citations indexed

About

Abigail Altabef is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Abigail Altabef has authored 6 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Abigail Altabef's work include Lung Cancer Research Studies (3 papers), Neuroblastoma Research and Treatments (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Abigail Altabef is often cited by papers focused on Lung Cancer Research Studies (3 papers), Neuroblastoma Research and Treatments (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Abigail Altabef collaborates with scholars based in United States and Spain. Abigail Altabef's co-authors include Kwok‐Kin Wong, Camilla L. Christensen, Caleb M. Yeung, Bandana Sharma, Nicholas Kwiatkowski, Edmond Chipumuro, Guo‐Cheng Yuan, Brian J. Abraham, Nathanael S. Gray and Antonio R. Pérez‐Atayde and has published in prestigious journals such as Cell, Cancer Research and Clinical Cancer Research.

In The Last Decade

Abigail Altabef

6 papers receiving 551 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer

2014 451 citations Edmond Chipumuro, Eugenio Marco et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Abigail Altabef United States	4	434	189	102	76	71	6	558
Clark M. Hatheway United States	2	405 0.9×	152 0.8×	65 0.6×	57 0.8×	69 1.0×	4	483
Robyn T. Sussman United States	11	331 0.8×	160 0.8×	61 0.6×	106 1.4×	48 0.7×	24	468
Bandana Sharma United States	8	662 1.5×	283 1.5×	128 1.3×	100 1.3×	107 1.5×	16	833
Amanda Balboni Iniguez United States	7	470 1.1×	207 1.1×	130 1.3×	75 1.0×	81 1.1×	7	604
Teresa Corral Spain	8	237 0.5×	164 0.9×	64 0.6×	34 0.4×	81 1.1×	15	434
Quan-Sheng Zhu United States	9	234 0.5×	148 0.8×	94 0.9×	39 0.5×	56 0.8×	9	413
Verónica Fernández Spain	11	314 0.7×	232 1.2×	71 0.7×	113 1.5×	43 0.6×	17	619
Octavio A. Romero Spain	12	575 1.3×	208 1.1×	95 0.9×	125 1.6×	33 0.5×	15	721
Lili T. Belcastro United States	4	336 0.8×	258 1.4×	195 1.9×	149 2.0×	212 3.0×	8	576
Barbara Lysy United States	7	380 0.9×	192 1.0×	150 1.5×	96 1.3×	18 0.3×	7	568

Countries citing papers authored by Abigail Altabef

Since Specialization

Citations

This map shows the geographic impact of Abigail Altabef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abigail Altabef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abigail Altabef more than expected).

Fields of papers citing papers by Abigail Altabef

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abigail Altabef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abigail Altabef. The network helps show where Abigail Altabef may publish in the future.

Co-authorship network of co-authors of Abigail Altabef

This figure shows the co-authorship network connecting the top 25 collaborators of Abigail Altabef. A scholar is included among the top collaborators of Abigail Altabef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abigail Altabef. Abigail Altabef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Engelman, Jeffrey A., Tanya Tupper, Liang Chen, et al.. (2020). Co-Clinical Trials Demonstrate Superiority of Crizotinib to Chemotherapy in ALK-Rearranged Non-Small Cell Lung Cancer and Predict Strategies to Overcome Resistance. UNC Libraries. 3 indexed citations

2.

Tchaicha, Jeremy H., Esra A. Akbay, Abigail Altabef, et al.. (2014). Kinase Domain Activation of FGFR2 Yields High-Grade Lung Adenocarcinoma Sensitive to a Pan-FGFR Inhibitor in a Mouse Model of NSCLC. Cancer Research. 74(17). 4676–4684. 30 indexed citations

3.

Chipumuro, Edmond, Eugenio Marco, Camilla L. Christensen, et al.. (2014). CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer. DSpace@MIT (Massachusetts Institute of Technology). 1 indexed citations

4.

Chipumuro, Edmond, Eugenio Marco, Camilla L. Christensen, et al.. (2014). CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer. Cell. 159(5). 1126–1139. 451 indexed citations breakdown →

5.

Chen, Zhao, Esra A. Akbay, Oliver R. Mikse, et al.. (2013). Co-Clinical Trials Demonstrate Superiority of Crizotinib to Chemotherapy in ALK -Rearranged Non–Small Cell Lung Cancer and Predict Strategies to Overcome Resistance. Clinical Cancer Research. 20(5). 1204–1211. 51 indexed citations

6.

Akbay, Esra A., Shohei Koyama, Julián Carretero, et al.. (2013). Abstract B290: Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors.. Molecular Cancer Therapeutics. 12(11_Supplement). B290–B290. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact